New questionnaire could help millions avoid kidney failure

NCT ID NCT05866276

Completed Diagnosis Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a short questionnaire called SCORED to see if it can accurately identify adults in Asia who are at risk for chronic kidney disease (CKD). Over 1,400 people took part across multiple hospitals. Researchers measured how well the questionnaire predicted kidney problems compared to standard lab tests. If effective, this tool could enable early detection and prevention in communities with limited access to healthcare.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If the questionnaire proves accurate, it could become a cheap, easy way to screen large populations for early kidney disease risk.
What could go wrong: This is an observational study, not a treatment trial. The questionnaire may not be accurate enough to replace standard tests, and results may not apply outside Asia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE

Contacts and locations

Locations

Nguyen Tri Phuong Hospital

Ho Chi Minh City, 70000, Vietnam
Perisai Husada

Bandung, West Java, 40115, Indonesia
Research Site

Surabaya, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.